Dr. Raymond Schinazi Wins the Lifetime Achievement Award at the 12th Annual Scrip Awards December 6, 2016 by Brace Pharma Capital
Brace will attending the 35th annual J.P. Morgan Healthcare Conference in San Francisco from January 9-11, 2016 November 28, 2016 by Brace Pharma Capital
Brace will attending the Biotech Showcase 2017 Conference in San Francisco from January 9-11, 2016 November 28, 2016 by Brace Pharma Capital
Brace will attending the RESI Conference in San Francisco on January 9, 2016 November 27, 2016 by Brace Pharma Capital
Brace will be attending the 28th annual Piper Jaffray Healthcare Conference in New York October 28, 2016 by Brace Pharma Capital
Brace will be attending the BIO Europe in Cologne, Germany on November 7-11, 2016 October 15, 2016 by Brace Pharma Capital
Institute of Human Virology honors Dr. Raymond Schinazi with Lifetime Achievement Award September 23, 2016 by Brace Pharma Capital
Zymeworks Doses First Patient in Phase 1 Trial of ZW25, a Novel Bi-Specific Antibody September 21, 2016 by Brace Pharma Capital
Brace will be attending the BIO Investor Forum in San Francisco on October 18-19 2016 September 19, 2016 by Brace Pharma Capital
Brace will be attending the Cell & Gene Therapy meeting on October 5-7th 2016 September 18, 2016 by Brace Pharma Capital
F2G Ltd Announces $60 Million Financing to Progress Development of Novel Antifungal Agents June 20, 2016 by Brace Pharma Capital
Brace will be attending the Redefining Early Stage Investments (RESI) Conference June 23, 2016 May 24, 2016 by Brace Pharma Capital
Brace will be attending the Jefferies 2016 Healthcare Conference June 7-10, 2016 May 9, 2016 by Brace Pharma Capital
Brace will be attending the World Orphan Drug Congress April 20-22 March 23, 2016 by Brace Pharma Capital
Brace will be attending the RESI Houston Conference on April 11 March 23, 2016 by Brace Pharma Capital
Brace will be attending Cowen and Company\’s 36th Annual Healthcare Conference March 7- 9, 2016 March 3, 2016 by Brace Pharma Capital
Zymeworks Announces $61.5 Million Financing to Support the Clinical Development of its Pipeline January 8, 2016 by Brace Pharma Capital